Global Kidney Stone Management Devices Market to Reach $1.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Kidney Stone Management Devices estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 3% over the analysis period 2020-2027. Extracorporeal Shock Wave Lithotripsy, one of the segments analyzed in the report, is projected to record a 1.1% CAGR and reach US$522.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Percutaneous Nephrolithotomy segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $346.5 Million, While China is Forecast to Grow at 5.2% CAGR
The Kidney Stone Management Devices market in the U.S. is estimated at US$346.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$313.1 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 2.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.
Intracorporeal Lithotripsy Segment to Record 4.4% CAGR
In the global Intracorporeal Lithotripsy segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$350.2 Million in the year 2020 will reach a projected size of US$455.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$219.1 Million by the year 2027, while Latin America will expand at a 5.4% CAGR through the analysis period. We bring years of research experience to this 16th edition of our report. The 189-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Becton Dickinson and Company
- Boston Scientific Corporation
- Coloplast Group
- Cook Medical
- Dornier MedTech
- E.M.S. Electro Medical Systems S.A.
- EDAP TMS SA
- Lumenis Ltd.
- Olympus Corporation
- Richard Wolf GmbH
- Siemens Healthineers
- Storz Medical AG